Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia areata progression is linked to stress and hormone changes, suggesting new treatment targets.

Hair disorders significantly affect quality of life, but treatment improves it.

The SAAD-41 is a valid tool for assessing distress in people with Alopecia Areata.

Homeopathic treatment may effectively manage alopecia areata.

Current treatments for alopecia areata in Chinese patients often lead to recovery with recurrence, showing a need for better management.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Photobiomodulation therapy effectively promotes hair regrowth and improves quality of life in alopecia areata without side effects.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Autologous follicular stem cells improved hair loss in 57% of patients.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Alopecia areata greatly affects the quality of life for children and their families.

Deucravacitinib helped a man regrow hair significantly.

Telogen effluvium most affects quality of life in alopecia patients.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

Hair regrowth improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Cases of alopecia areata and its impact on life quality rose globally, but when adjusted for age, the rates decreased, especially in poorer regions.

Hair loss and mental health issues like anxiety and insomnia affect each other, impacting quality of life.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Disease-specific tools better assess quality of life in alopecia areata patients.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

The document focused on hair disorders, especially alopecia, and discussed treatments and impacts on quality of life.

Comprehensive medical and psychosocial support is essential to improve the quality of life for alopecia areata patients.

Identifying alopecia types early is crucial for better treatment and quality of life.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Early dermatological referrals are important for women and girls with Turner syndrome to improve life quality.

Vitiligo patients are willing to pay the most for treatment, regardless of disease severity.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.